Comparing emergency spacers to traditional spacers for delivering asthma medication
Official title: Assessment of Emergency Spacers Versus Traditional Spacers for Delivery of Aerosolized Drugs
Run by Beni-Suef University · NCT06816342 · Data updated 2026-11-12
This study is testing whether using emergency spacers instead of traditional spacers helps deliver asthma medication more effectively for both kids and adults.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 6 Years to 80 Years |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | Beni-Suef University Academic / other |
| Locations | 1 site (Banī Suwayf, Egypt) |
| Status | Recruiting |
| Started | November 1, 2024 |
| Main results expected | February 10, 2025 |
| Study ends | February 10, 2025 |
| Registry record updated | February 10, 2025 |
| Trial ID | NCT06816342 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are mild to moderate asthmatic patients aged 6 to 80 years.
✕Probably not a fit
Patients with severe asthma, those in intensive care, or individuals with certain health conditions such as ischemic heart disease or hypersensitivity to salbutamol may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial evaluates the performance, feasibility, and safety of emergency spacers versus traditional spacers for delivering aerosolized drugs using pressurized metered-dose inhalers (pMDI) in both young children and adult asthmatic patients. The study aims to measure the total emitted dose from pMDI, assess pharmacokinetic parameters, and evaluate lung and systemic bioavailability of the aerosol delivered by different spacers. Additionally, it will analyze lung function post-delivery and monitor safety outcomes. By comparing the effectiveness of various spacers, the trial seeks to improve asthma management through better medication delivery.
Why it matters
Potential benefit: If successful, this study could enhance the effectiveness of asthma treatment by optimizing aerosol drug delivery methods.
How similar studies have gone: Other studies have shown promising results in improving aerosol delivery methods, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: • Mild and moderate asthmatic patients aged from 6 - 80 year old. Exclusion Criteria: * Severe asthmatics or patients admitted to an intensive care unit * ischemic heart disease * recent abdominal surgery * inability to perform properly the pulmonary function tests * hepatic or renal impairment * hypersensitivity to salbutamol.
Where it's running
-
Beni-Suef university hospital
Banī Suwayf, Egypt, Egypt Recruiting
Study contacts
- Study coordinator: Omar Ahmed Sayed, Demonstrator
- Email: OmarAhmed@pharm.bsu.edu.eg
- Phone: +201152677683
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bubble-like dome to contain airborne germs during endotracheal intubation
This trial tests whether placing a clear, bubble-shaped dome over a patient’s head during intubation can help reduce germ spread without making the anesthesia process harder.
-
Pulmonary and cardiovascular rehabilitation program for chronic respiratory and heart conditions
This study tests a rehabilitation program that combines exercise for people with chronic lung and heart conditions to see if it helps them feel better and improve their daily activities.
-
Assessing diaphragm function in patients with respiratory diseases
This study is testing how well the diaphragm works in people with respiratory diseases to see if it affects their breathing difficulties and overall health.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.